News & Updates
Filter by Specialty:
Testosterone therapy in women may lower risks of MACE, breast cancer
Women on testosterone therapy (TTh) show a lower risk of major adverse cardiac events (MACE) than matched controls, while postmenopausal women have a comparable MACE risk and a similar or significantly reduced risk of breast cancer on age-based subanalysis, reports a study.
Testosterone therapy in women may lower risks of MACE, breast cancer
04 Jun 2024
Increasing trend in DOAC-related intracerebral haemorrhage: How to improve outcomes?
New local findings presented at HKMF 2024 show an increasing trend in intracerebral haemorrhage (ICH) among patients on direct oral anticoagulants (DOACs) between 2013 and 2022. Early initiation of reversal agents may improve outcomes in select cases with DOAC-related ICH.
Increasing trend in DOAC-related intracerebral haemorrhage: How to improve outcomes?
30 May 2024
Impaired thyroid hormone sensitivity ups MACE risk in angiography patients
Euthyroid patients undergoing coronary angiography who have impaired sensitivity to thyroid hormone are at increased risks of major adverse cardiovascular events (MACE) and cardiovascular death, a recent study has shown.
